The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

The FDA has updated labels on the top two COVID-19 vaccines to warn of a rare heart side effect, mostly seen in young men.

The Food and Drug Administration said Wednesday it was expanded existing warnings on the two leading COVID vaccines about a ...

The U.S. Food and Drug Administration (FDA) has added new warnings to the Pfizer and Moderna COVID-19 vaccines about a rare ...

Crohn's Disease Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a ...

Patients with psoriatic arthritis (PsA) have a higher prevalence of diabetes mellitus (DM) compared to the general population ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

Global Functional Dyspepsia Drug Market is valued approximately at USD 10.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.92% over the forecast period 2024-2032 ...

In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...